Back to Search
KRISTINE ZANOTTI, MD
MD
Gynecologic Oncology Physician
NPI: 1487673265Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
35-077677(OH)
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
77677(OH)35.077677(OH)
Research & Publications (20)
Update on the diagnosis and treatment of human papillomavirus infection.
PMID 12546268·Cleve Clin J Med·2002
6-review
Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy.
PMID 11408510·J Clin Oncol·2001
8-other
Prevention and management of antineoplastic-induced hypersensitivity reactions.
PMID 11676304·Drug Saf·2001
6-review
Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy.
PMID 11063646·Gynecol Oncol·2000
8-other
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
PMID 19306417·Cancer·2009
4-observational
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
PMID 19118888·Gynecol Oncol·2009
4-observational
Thermodynamics of the fragile X mental retardation protein RGG box interactions with G quartet forming RNA.
PMID 16819831·Biochemistry·2006
8-other
New cervical cancer screening strategy: combined Pap and HPV testing.
PMID 15757169·Cleve Clin J Med·2005
8-other
Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers.
PMID 15863132·Gynecol Oncol·2005
8-other
Molecular dynamics simulation studies of the effect of phosphocitrate on crystal-induced membranolysis.
PMID 16040742·Biophys J·2005
7-preclinical
Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
PMID 15099951·Gynecol Oncol·2004
8-other
Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials.
PMID 15196867·Gynecol Oncol·2004
8-other
Examples of the marked variability in the relationship between the serum CA-125 antigen level and cancer-related symptoms in ovarian cancer.
PMID 15196871·Gynecol Oncol·2004
5-case
Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
PMID 15262133·Gynecol Oncol·2004
8-other
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.
PMID 15284263·J Clin Oncol·2004
8-other
Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneum.
PMID 15297180·Gynecol Oncol·2004
3-trial
Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum.
PMID 15331919·Oncology·2004
3-trial
Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancers.
PMID 15385118·Gynecol Oncol·2004
3-trial
Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers.
PMID 15338296·J Cancer Res Clin Oncol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-3941
Quick Facts
- NPI
- 1487673265
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile